AIG
OVID icon

American International Group’s Ovid Therapeutics OVID Stock Holding History

American International Group’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,386
Closed -$89.6K – 1904
2024
Q1 		$89.6K Sell
29,386
-253
-0.9% -$847 ﹤0.01% 2579
2023
Q4 		$95.4K Sell
29,639
-120
-0.4% -$410 ﹤0.01% 2589
2023
Q3 		$114K Buy
29,759
+1,058
+4% +$3.8K ﹤0.01% 2436
2023
Q2 		$94.1K Buy
+28,701
New +$97.5K ﹤0.01% 2615
2021
Q2 		– Sell
-27,729
Closed -$111 – 3230
2021
Q1 		$111 Buy
27,729
+74
+0.3% +$246 ﹤0.01% 2661
2020
Q4 		$64 Buy
27,655
+2,055
+8% +$9.58K ﹤0.01% 2876
2020
Q3 		$147K Sell
25,600
-583
-2% -$3.9K ﹤0.01% 2313
2020
Q2 		$193K Buy
+26,183
New +$122K ﹤0.01% 2139
2019
Q2 		– Sell
-8,401
Closed -$15K – 3143
2019
Q1 		$15K Sell
8,401
-273
-3% -$683 ﹤0.01% 3013
2018
Q4 		$21K Sell
8,674
-67
-0.8% -$306 ﹤0.01% 3018
2018
Q3 		$50K Buy
8,741
+158
+2% +$1.2K ﹤0.01% 3065
2018
Q2 		$67K Buy
8,583
+743
+9% +$6.38K ﹤0.01% 2927
2018
Q1 		$55K Buy
7,840
+4,437
+130% +$35.9K ﹤0.01% 2880
2017
Q4 		$34K Buy
3,403
+17
+0.5% +$156 ﹤0.01% 2984
2017
Q3 		$29K Buy
3,386
+254
+8% +$2.12K ﹤0.01% 2819
2017
Q2 		$33K Buy
+3,132
New +$40.9K ﹤0.01% 3032

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American International Group's OVID Position: Q2 2024 in Review

American International Group sold out of Ovid Therapeutics (OVID) in Q2 2024, closing a stake of 29,386 shares — an estimated $89.6K sold.

American International Group first reported a position in OVID in Q2 2017 and held it in 16 quarters. The position peaked at $193K in Q2 2020. 74 funds tracked by Wall St. Rank hold OVID as of Q2 2024.

  • American International Group reported no remaining Ovid Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 29,386 Ovid Therapeutics shares in Q2 2024, an estimated $89.6K.
  • American International Group first reported a position in Ovid Therapeutics in Q2 2017 and held it in 16 quarters.
  • American International Group's Ovid Therapeutics position peaked at $193K in Q2 2020.
  • 74 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.